Impact of Severe Obstructive Sleep Apnea-Hypopnea Syndrome on Auditory-Cognitive Processing

NCT ID: NCT07039500

Last Updated: 2025-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-11

Study Completion Date

2025-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn how severe obstructive sleep apnea-hypopnea syndrome (OSAHS) affects the brain's ability to process sounds and attention in adults aged 20-60 years. The main questions it aims to answer are:

1. Does severe OSAHS change how the brain automatically detects sound changes during wakefulness?
2. Does severe OSAHS reduce people's ability to pay attention to important sounds when awake?
3. Can brainwave tests (Electroencephalogram, EEG) detect early signs of hearing-related cognitive problems in OSAHS patients before symptoms appear?

Researchers will compare two groups:

* 50 adults with severe OSAHS (diagnosed by sleep tests)
* 50 healthy adults matched by age and gender

Participants will:

* Complete hearing tests (MoCA)
* Undergo a 1-night sleep test (PSG)
* Wear an EEG cap for 1.5-2 hours while listening to sounds in a quiet room:

* Passive task: Relax (no response needed)
* Active task: Press a button when hearing rare sounds
* Receive ¥75/hour compensation for their time

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea Auditory Processing Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Severe OSAHS Group

Adults aged 20-60 years with severe obstructive sleep apnea-hypopnea syndrome (AHI\>30 events/hour) confirmed by polysomnography (PSG). Participants undergo PSG, hearing tests (pure-tone audiometry, tympanometry), Montreal Cognitive Assessment (MoCA), and EEG recording during active/passive auditory oddball tasks measuring MMN, P300, and behavioral responses.

No interventions assigned to this group

Healthy Control Group

Age/sex-matched healthy adults (20-60 years) with self-reported absence of snoring/sleep disorders. Participants complete hearing tests (pure-tone audiometry, tympanometry), Montreal Cognitive Assessment (MoCA), and EEG recording during identical auditory oddball tasks as the OSAHS group.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All Participants:

* Aged 20-60 years
* Normal hearing (PTA ≤25 dB HL at 0.5,1,2,4 kHz; Type A tympanogram)
* MoCA score ≥26
* Willing to complete EEG testing

OSAHS Group Additional:

\- PSG-confirmed severe OSAHS (AHI \>30 events/hour)

Control Group Additional:

* Self-reported absence of snoring/sleep disorders
* No prior OSAHS diagnosis

Exclusion Criteria

All Participants:

* History of:

* Schizophrenia, epilepsy, Parkinson's, TBI, or language disorders
* Middle/inner ear diseases (otitis media, acoustic neuroma, etc.)
* Cognitive impairment or depression/anxiety disorders
* Chronic steroid use
* Systemic inflammatory diseases or malignancies
* Pregnancy or suspected pregnancy (self-reported)
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University First Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University First Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Caifeng Xia, M.D.

Role: CONTACT

+8618811173785

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Caifeng Xia, M.D.

Role: primary

+8618811173785

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PekingUFH-2024RES651-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.